[PETDAG] QoQ Annualized Quarter Result on 31-Mar-2009 [#4]

Stock
[PETDAG] PETRONAS DAGANGAN BHD
Announcement Date
25-May-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2009
Quarter
31-Mar-2009 [#4]
Profit Trend
QoQ- 6.81%
YoY- -12.54%
Quarter Report
Latest QR
Upcoming QR
PETDAG's Result
PETDAG's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 CAGR
Revenue 20,359,398 19,863,672 19,119,464 24,367,622 26,656,829 28,862,484 26,964,196 -17.03%
PBT 1,086,540 1,115,960 1,128,264 810,292 765,814 1,012,102 1,292,448 -10.89%
Tax -293,128 -302,110 -302,240 -228,533 -218,922 -278,976 -358,424 -12.51%
NP 793,412 813,850 826,024 581,759 546,892 733,126 934,024 -10.27%
-
NP to SH 789,102 809,160 821,448 578,671 541,760 727,712 928,812 -10.27%
-
Tax Rate 26.98% 27.07% 26.79% 28.20% 28.59% 27.56% 27.73% -
Total Cost 19,565,986 19,049,822 18,293,440 23,785,863 26,109,937 28,129,358 26,030,172 -17.28%
-
Net Worth 4,398,982 4,324,134 4,365,182 4,166,033 3,993,658 4,036,216 4,147,899 3.98%
Dividend
31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 CAGR
Div - 298,216 - 447,426 - 238,594 - -
Div Payout % - 36.86% - 77.32% - 32.79% - -
Equity
31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 CAGR
Net Worth 4,398,982 4,324,134 4,365,182 4,166,033 3,993,658 4,036,216 4,147,899 3.98%
NOSH 992,998 994,054 992,086 994,280 993,447 994,142 992,320 0.04%
Ratio Analysis
31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 CAGR
NP Margin 3.90% 4.10% 4.32% 2.39% 2.05% 2.54% 3.46% -
ROE 17.94% 18.71% 18.82% 13.89% 13.57% 18.03% 22.39% -
Per Share
31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 CAGR
RPS 2,050.30 1,998.25 1,927.20 2,450.78 2,683.27 2,903.26 2,717.29 -17.07%
EPS 79.47 81.40 82.80 58.20 54.53 73.20 93.60 -10.30%
DPS 0.00 30.00 0.00 45.00 0.00 24.00 0.00 -
NAPS 4.43 4.35 4.40 4.19 4.02 4.06 4.18 3.93%
Adjusted Per Share Value based on latest NOSH - 996,237
31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 CAGR
RPS 2,049.36 1,999.46 1,924.54 2,452.82 2,683.25 2,905.27 2,714.19 -17.03%
EPS 79.43 81.45 82.69 58.25 54.53 73.25 93.49 -10.26%
DPS 0.00 30.02 0.00 45.04 0.00 24.02 0.00 -
NAPS 4.428 4.3526 4.3939 4.1935 4.02 4.0628 4.1752 3.98%
Price Multiplier on Financial Quarter End Date
31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 CAGR
Date 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 -
Price 8.70 8.60 8.35 7.90 7.20 6.55 7.50 -
P/RPS 0.42 0.43 0.43 0.32 0.27 0.23 0.28 30.94%
P/EPS 10.95 10.57 10.08 13.57 13.20 8.95 8.01 23.10%
EY 9.13 9.47 9.92 7.37 7.57 11.18 12.48 -18.76%
DY 0.00 3.49 0.00 5.70 0.00 3.66 0.00 -
P/NAPS 1.96 1.98 1.90 1.89 1.79 1.61 1.79 6.21%
Price Multiplier on Announcement Date
31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 CAGR
Date 19/02/10 23/11/09 25/08/09 25/05/09 24/02/09 25/11/08 28/08/08 -
Price 8.58 8.70 8.61 7.95 7.45 7.05 6.55 -
P/RPS 0.42 0.44 0.45 0.32 0.28 0.24 0.24 45.07%
P/EPS 10.80 10.69 10.40 13.66 13.66 9.63 7.00 33.41%
EY 9.26 9.36 9.62 7.32 7.32 10.38 14.29 -25.05%
DY 0.00 3.45 0.00 5.66 0.00 3.40 0.00 -
P/NAPS 1.94 2.00 1.96 1.90 1.85 1.74 1.57 15.10%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment